PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop improved methods for quantifying the phenomena that regulate tumors' ability to metastasize.
Read the commentary here.
Important News
We are pleased to announce that Altium has acquired the assets and intellectual property of PHI AB, including the HoloMonitor product line. This marks an exciting new chapter for label-free live cell analysis; one that will bring greater resources, broader reach, and continued innovation to the researchers and organizations who rely on HoloMonitor every day.
For all product and service inquiries, please contact the Altium team. We look forward to supporting you.
Thank you for being part of the HoloMonitor community.
Altium HoloMonitor Info — info.holomonitor@altium.net (general product inquiries)
Altium HoloMonitor Support — support.holomonitor@altium.net (service inquiries)